Illinois Municipal Retirement Fund’s Sarepta Therapeutics SRPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-4,709
Closed -$301K 1364
2025
Q1
$301K Hold
4,709
﹤0.01% 1305
2024
Q4
$573K Hold
4,709
0.01% 1179
2024
Q3
$588K Buy
+4,709
New +$651K 0.01% 1161
2023
Q4
Sell
-6,467
Closed -$784K 1398
2023
Q3
$784K Hold
6,467
0.01% 958
2023
Q2
$741K Hold
6,467
0.01% 714
2023
Q1
$891K Buy
6,467
+2,042
+46% +$265K 0.02% 647
2022
Q4
$573K Buy
+4,425
New +$513K 0.01% 750
2021
Q2
Sell
-2,201
Closed -$164K 874
2021
Q1
$164K Hold
2,201
0.01% 843
2020
Q4
$375K Buy
+2,201
New +$326K 0.02% 737

Other funds holding SRPT

Illinois Municipal Retirement Fund's SRPT Position: Q2 2025 in Review

Illinois Municipal Retirement Fund sold out of Sarepta Therapeutics (SRPT) in Q2 2025, closing a stake of 4,709 shares — an estimated $301K sold.

Illinois Municipal Retirement Fund first reported a position in SRPT in Q4 2020 and held it in 9 quarters. The position peaked at $891K in Q1 2023. 363 funds tracked by Wall St. Rank hold SRPT as of Q2 2025.

  • Illinois Municipal Retirement Fund reported no remaining Sarepta Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Illinois Municipal Retirement Fund sold 4,709 Sarepta Therapeutics shares in Q2 2025, an estimated $301K.
  • Illinois Municipal Retirement Fund first reported a position in Sarepta Therapeutics in Q4 2020 and held it in 9 quarters.
  • Illinois Municipal Retirement Fund's Sarepta Therapeutics position peaked at $891K in Q1 2023.
  • 363 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2025.

Based on Illinois Municipal Retirement Fund's 13F filing for Q2 2025, filed 7 Aug 2025.